At CES in Las Vegas, the focus was not on the buzz, but on substance. SunLED’s near-infrared technology was repeatedly highlighted by international media as a promising health and medtech solution. In particular, the SunBooster drew attention as a tangible, practical product addressing a growing health challenge: the lack of natural (near-infrared) light in an increasingly indoor lifestyle.
What stood out in the coverage was the emphasis on technological validation and market potential. Media outlets not only underlined the scientific evidence behind the SunBooster, but also its scalability toward consumer electronics, workplaces, and medical applications. This aligns with SunLED’s strategic positioning: a platform technology that can be integrated into existing ecosystems, rather than a standalone gadget.
In addition, SunLED CEO Anne Berends gave several interviews in which she explained how years of research are now converging into a product ready for market introduction. Her message was not about distant promises, but about concrete steps: industrial partners, initial production, and a clear path to commercialization.
For Momentum, this international attention primarily confirms one thing: the underlying technology works, is understood, and is being taken seriously by the market. That is a crucial step in building value.
In the international press, SunLED’s technology was covered by, among others, Fox News and ZDNET. They spoke with Anne Berends about the scientifically validated technology behind the SunBooster and the roadmap toward international scale-up.
